(Q51300790)

3 April 2018

title

Circulating irisin levels are associated with lipid and uric acid metabolism in a Chinese population. (English)

1 reference

3 April 2018

author name string

Shanshan Tang

1

1 reference

3 April 2018

Rong Zhang

2

1 reference

3 April 2018

Feng Jiang

3

1 reference

3 April 2018

Jie Wang

4

1 reference

3 April 2018

Miao Chen

5

1 reference

3 April 2018

Danfeng Peng

6

1 reference

3 April 2018

Jing Yan

7

1 reference

3 April 2018

Shiyun Wang

8

1 reference

3 April 2018

Yuqian Bao

9

1 reference

3 April 2018

Cheng Hu

10

1 reference

3 April 2018

Weiping Jia

11

1 reference

3 April 2018

publication date

26 June 2015

1 reference

3 April 2018

Clinical and Experimental Pharmacology and Physiology

published in

1 reference

3 April 2018

Association of serum uric acid and metabolic syndrome in type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Weight gain as a risk factor for clinical diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Muscles, exercise and obesity: skeletal muscle as a secretory organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Physical activity and exercise in the regulation of human adipose tissue physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Irisin, turning up the heat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Development of obesity in transgenic mice after genetic ablation of brown adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Brown adipose tissue in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Lower circulating irisin is associated with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Irisin in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Association of serum irisin with metabolic syndrome in obese Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Serum irisin levels in new-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus - correlation with pancreatic β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Decrease in irisin in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Endoplasmic reticulum stress, obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12439

21 January 2018

Identifiers

DOI

10.1111/1440-1681.12439

1 reference

3 April 2018

PubMed ID

26111934

1 reference

3 April 2018